Background
In recent decades, genome-edited fish production is gaining momentum among aquaculturists, but uncertainties about off-target mutations is a major concern for commercialization of genome-edited fish products. Recently, a knockout (KO) Scomber japonicus (chub mackerel) strain of arginine vasotocin receptor V1a2 (V1a2) was developed using TALEN to reduce the cannibalism frequency of fry. Aside from this behavioral trait, the KO fish had no other phenotypic differences with their wild counterpart. Whether the changed trait is an outcome of unwanted mutation in the genome or not, is a prerequisite for consumer’s safety and psychological satisfaction and thus needs careful genome-wide analysis. Therefore, the objective of this study was to detect and evaluate potential off-target sites in the genome-edited V1a2-KO chub mackerel strain.
Results
In the V1a2-KO strain, approximately 0.9 million variants were identified through specific variant extraction. To assess potential off-target effects, putative mutagenesis sites for TALEN were predicted using the chub mackerel reference genome (available at NCBI), and the top 1,000 sites with lowest binding scores (indicating stronger predicted binding affinity) were selected. Comparison of these 1,000 predicted TALEN binding sites with ~ 0.9 million variants revealed 24 overlapping sites. Among them, only one site, corresponding to the target gene V1a2 (13-base deletion), having the lowest binding score of 12. 76, was located within a coding sequence (CDS), suggesting no phenotypic side effects in the V1a2-KO strain. Additional, expected number of variants analysis confirmed that the remaining observed variations might be an outcome of spontaneous mutation.
Conclusion
Using genome-wide assessment and comparison with predicted TALEN binding sites, of genome-edited individuals with their close and distant relatives, we have identified 24 probable sites, among which only one, the 13 base deletion was located in the target gene’s CDS strongly indicating no off-target associated phenotypic changes. Cumulatively, our results confirms the precision of TALEN genome-editing system and safety of TALEN genome-edited products and strongly raises the possibility of commercialization of V1a2-KO chub mackerel strain in future.